Various-Coronavirus/AstraZeneca

Several European countries set age limit on AstraZeneca jab

  • English
  • Français
  • العربية
  • Pусский
  • Español
  • 日本語
  • Deutsch

Shotlist


FILE: Bristol, UK - 2021 (CGTN - No access Chinese mainland)
1. Various of medical worker preparing for vaccination with AstraZeneca vaccine
2. Various of elderly woman receiving AstraZeneca vaccine

FILE: London, UK - May 2, 2020 (CCTV - No access Chinese mainland)
3. UK national flag

FILE: London, UK - Jan 6, 2021 (CCTV - No access Chinese mainland)
4. "Keep Safe" sign at roadside

FILE: London, UK - Jan 12, 2021 (CCTV - No access Chinese mainland)
5. Various of pedestrians; buildings; traffic
6. Empty street
7. Tower Bridge

FILE: Madrid, Spain - Exact Date Unknown (CCTV - No access Chinese mainland)
8. Spanish national flag

Madrid, Spain - March 24, 2021 (CGTN - No access Chinese mainland)
9. Various of medical workers, residents in COVID-19 vaccination center; residents receiving vaccine

FILE: Madrid, Spain - Oct 3, 2020 (CGTN - No access Chinese mainland)
10. Various of pedestrians, people dining outdoor

FILE: Brussels, Belgium - Exact Date Unknown 2020 (CGTN - No access Chinese mainland)
11. Various of closed restaurants
12. Various of pedestrians; sign of mask wearing mandate
13. Various of medical staff dealing tubes of nucleic acid test at lab
14. Machine lifting tubs

Storyline


Many countries in Europe have set the limit to age for the use of Oxford-AstraZeneca COVID-19 vaccine following occurrences of blood clot case after the jab.

In the United Kingdom, people aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine amid concerns over its possible link to reported rare cases of blood clots, the British government's vaccination advisory body, the Joint Committee on Vaccination and Immunization (JCVI), said Wednesday.

The announcement by the JCVI follows a review of the Oxford vaccine by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA said the side-effects of the AstraZeneca vaccine were extremely rare and the vaccine's effectiveness is proven, adding that the benefits of taking the vaccine are still very favorable for the vast majority.

However, it conceded the new approach is more finely balanced for younger people because the risk from coronavirus is much lower.

According to the MHRA, Britain has vaccinated more than 20 million people with the AstraZeneca vaccine and up to March 31, 79 cases of rare blood clots were reported, including 51 women and 28 men aged 18-79.

Also, on Wednesday, the European Medicines Agency (EMA) confirmed that the occurrence of blood clots with low blood platelets are strongly associated with the administration of AstraZeneca vaccine but should be still listed as a very rare side-effect.

In its latest assessment, EMA experts told the media that the reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.

EMA's Pharmacovigilance Risk Assessment Committee made the conclusion after carrying out an in-depth review of the more than 80 cases reported in the European Union (EU) database.

Following the EMA’s assessment, Spain has limited the use of AstraZeneca vaccine on Wednesday. The country announced to ban the use of the very vaccine for people under 60 and only to inoculate people aged 60-65.

Belgium also decided to set age limit for the use of the AstraZeneca vaccine, which is for use by aged 55 and above, according to local media on Wednesday.

A number of countries, as among them Canada, the Netherlands and Germany, have also suspended or limited the use of the AstraZeneca vaccine due to safety concerns.

DOWNLOAD
  • ID : 8186507
  • Dateline : April 7, 2021
  • Location : Various
  • Category : health
  • Duration : 2'06
  • Audio Language : Nats/Part Mute
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : No access Chinese mainland
  • Published : 2021-04-08 10:17
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1
  • ID : 8186507
  • Dateline : 7 avr. 2021
  • Location : Divers
  • Category : health
  • Duration : 2'06
  • Audio Language : Nats/Partiellement muet
  • Source : China Central Television (CCTV)
  • Restrictions : Pas d’accès dans la partie continentale de Chine
  • Published : 2021-04-08 16:26
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1
  • ID : 8186507
  • Dateline : 7 أبريل 2021
  • Location : الأماكن المختلفة
  • Category : health
  • Duration : 2'06
  • Audio Language : الصوت الطبيعي/صامت جزئيا
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : No access Chinese mainland
  • Published : 2021-04-08 16:40
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1
  • ID : 8186507
  • Dateline : Архив
  • Location : Многосторонние
  • Category : health
  • Duration : 2'06
  • Audio Language : Естественный звук/Частично немое
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : Недоступно материковой части Китая
  • Published : 2021-04-08 16:19
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1
  • ID : 8186507
  • Dateline : 7 abr. 2021
  • Location : Varios
  • Category : health
  • Duration : 2'06
  • Audio Language : Nats/Parte Muda
  • Source : China Central Television (CCTV)
  • Restrictions : No acceso a la parte continental de China
  • Published : 2021-04-08 18:35
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1
  • ID : 8186507
  • Dateline : 2021年4月7日
  • Category : health
  • Duration : 2'06
  • Audio Language : 自然音声/一部音声なし
  • Source : China Central Television (CCTV)
  • Restrictions : 中国大陸での使用は不可
  • Published : 2021-04-08 20:12
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1
  • ID : 8186507
  • Dateline : 7. April 2021
  • Category : health
  • Duration : 2'06
  • Audio Language : Originalton/ Teilweise ohne Ton
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : Für das chinesische Festland nicht verfügbar
  • Published : 2021-04-08 17:28
  • Last Modified : 2021-04-08 20:18:05
  • Version : 1

Various-Coronavirus/AstraZeneca

Several European countries set age limit on AstraZeneca jab

Dateline : April 7, 2021

Location : Various

Duration : 2'06

  • English
  • Français
  • العربية
  • Pусский
  • Español
  • 日本語
  • Deutsch


FILE: Bristol, UK - 2021 (CGTN - No access Chinese mainland)
1. Various of medical worker preparing for vaccination with AstraZeneca vaccine
2. Various of elderly woman receiving AstraZeneca vaccine

FILE: London, UK - May 2, 2020 (CCTV - No access Chinese mainland)
3. UK national flag

FILE: London, UK - Jan 6, 2021 (CCTV - No access Chinese mainland)
4. "Keep Safe" sign at roadside

FILE: London, UK - Jan 12, 2021 (CCTV - No access Chinese mainland)
5. Various of pedestrians; buildings; traffic
6. Empty street
7. Tower Bridge

FILE: Madrid, Spain - Exact Date Unknown (CCTV - No access Chinese mainland)
8. Spanish national flag

Madrid, Spain - March 24, 2021 (CGTN - No access Chinese mainland)
9. Various of medical workers, residents in COVID-19 vaccination center; residents receiving vaccine

FILE: Madrid, Spain - Oct 3, 2020 (CGTN - No access Chinese mainland)
10. Various of pedestrians, people dining outdoor

FILE: Brussels, Belgium - Exact Date Unknown 2020 (CGTN - No access Chinese mainland)
11. Various of closed restaurants
12. Various of pedestrians; sign of mask wearing mandate
13. Various of medical staff dealing tubes of nucleic acid test at lab
14. Machine lifting tubs


Many countries in Europe have set the limit to age for the use of Oxford-AstraZeneca COVID-19 vaccine following occurrences of blood clot case after the jab.

In the United Kingdom, people aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine amid concerns over its possible link to reported rare cases of blood clots, the British government's vaccination advisory body, the Joint Committee on Vaccination and Immunization (JCVI), said Wednesday.

The announcement by the JCVI follows a review of the Oxford vaccine by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA said the side-effects of the AstraZeneca vaccine were extremely rare and the vaccine's effectiveness is proven, adding that the benefits of taking the vaccine are still very favorable for the vast majority.

However, it conceded the new approach is more finely balanced for younger people because the risk from coronavirus is much lower.

According to the MHRA, Britain has vaccinated more than 20 million people with the AstraZeneca vaccine and up to March 31, 79 cases of rare blood clots were reported, including 51 women and 28 men aged 18-79.

Also, on Wednesday, the European Medicines Agency (EMA) confirmed that the occurrence of blood clots with low blood platelets are strongly associated with the administration of AstraZeneca vaccine but should be still listed as a very rare side-effect.

In its latest assessment, EMA experts told the media that the reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.

EMA's Pharmacovigilance Risk Assessment Committee made the conclusion after carrying out an in-depth review of the more than 80 cases reported in the European Union (EU) database.

Following the EMA’s assessment, Spain has limited the use of AstraZeneca vaccine on Wednesday. The country announced to ban the use of the very vaccine for people under 60 and only to inoculate people aged 60-65.

Belgium also decided to set age limit for the use of the AstraZeneca vaccine, which is for use by aged 55 and above, according to local media on Wednesday.

A number of countries, as among them Canada, the Netherlands and Germany, have also suspended or limited the use of the AstraZeneca vaccine due to safety concerns.

ID : 8186507

Published : 2021-04-08 10:17

Last Modified : 2021-04-08 20:18:05

Source : China Central Television (CCTV),China Global Television Network (CGTN)

Restrictions : No access Chinese mainland

More



Login
Username
Password
code
Sign In
OK